| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000024717 |
| Receipt No. | R000028436 |
| Official scientific title of the study | A research of intestinal environment of subjects who have ingested foods containing Bifidobacterium capsules for long term |
| Date of disclosure of the study information | 2016/11/07 |
| Last modified on | 2018/02/22 (Ver. 9) |
| Basic information | ||
| Official scientific title of the study | A research of intestinal environment of subjects who have ingested foods containing Bifidobacterium capsules for long term | |
| Title of the study (Brief title) | A research of intestinal environment of subjects who have ingested foods containing Bifidobacterium capsules for long term | |
| Region |
|
|
| Condition | |||
| Condition | Adults in good health | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To research intestinal environment of subjects who have ingested foods containing Bifidobacterium capsules for long term |
| Basic objectives2 | Others |
| Basic objectives -Others | Research |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | 16S metagenome analysis of gut microbiota.
Metabolome analysis of intestinal metabolites. |
| Key secondary outcomes | Questionnaire |
| Base | |
| Study type | Others,meta-analysis etc |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Males and females aged 40 to 60 years old when obtaining informed consent.
2) Subjects who have been ingesting foods containing Bifidobacterium capsules regularly for more than four years. 3) Subjects whose ingestion rate of foods containing Bifidobacterium capsules is more than 80%. 4) Subjects who don't ingest supplement regularly except foods containing Bifidobacterium capsules. 5) Subjects who don't take fermented foods, yogurt and/or dietary fiber foods etc. regularly, for intestinal regulation. 6) Subjects who don't use medicines on a daily basis. 7) Subjects who show understanding of the study procedures and agreement with participating the study by written informed consent prior to the study. |
|||
| Key exclusion criteria | 1) Subjects who have undergone abdominal surgical operation within 6 month before the questionnaire.
2) Subjects who have taken antibiotics at least once within 6 month before the questionnaire. 3) Subjects who expect to have a big change on their lifestyle before and/or after feces sampling. 4) Subjects with tendency of chronic diarrhea. 5) Subjects considered inadequate for the current test due to their medical history of serious liver, kidney and heart disease. 6) Subjects suspected to have chronic or acute infectious disease. 7) Pregnant or possibly pregnant women, or lactating women. |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Yukimasa Tanaka |
| Organization | MORISHITA JINTAN CO.,LTD. |
| Division name | Jintan Biopharma Research Laboratory, Research & Development Division |
| Address | 11-1, Tsudayamate 2-Chome, Hirakata-City, Osaka,540-8566, JAPAN |
| TEL | 072-800-1044 |
| yukimasa-tanaka@jintan.co.jp | |
| Public contact | |
| Name of contact person | Mamiko Kohno |
| Organization | MORISHITA JINTAN CO.,LTD. |
| Division name | Jintan Biopharma Research Laboratory, Research & Development Division |
| Address | 6F Ascend-kanda Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047, JAPAN |
| TEL | 03-6206-8138 |
| Homepage URL | |
| m_kohno@jintan.co.jp | |
| Sponsor | |
| Institute | MORISHITA JINTAN CO.,LTD. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Own resources |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | MetaGen,Inc. |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Study design: Research
Subject recruitment method: Subjects will be selected from adult applicants according to selection criteria and exclusion criteria, and in consideration of the balance of their age and sex. Measurement items: 16S metagenome analysis and metabolome analysis of fecales samples. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028436 |